Koomesh
Journal of Semnan University of Medical Sciences
Outlines
Metabolome profile comparison of cisplatin sensitive and resistant in ovarian epithelial cells by magnetic resonance spectroscopy spectroscopy
Ziba Akbari, A. li Awsat Mellati, Amir Amanzadeh, Aboalfazl Nazarian, Zahra Zamani, Mohammad Arjmand
,*Abstract
References
- 1.Metzger-Filho O, Moulin C, D'Hondt V. First-line systemic treatment of ovarian cancer: a critical review of available evidence and expectations for future directions. Curr Opin Oncol 2010; 22: 513-520.
- 2.Akbari ME KM. Incidence, mortality and burden of cancers in Iran. Cancer Res Shahid Beheshti Univ Med Sci 2008: 95-125. (Persian).
- 3.Kurman RJ, Shih Ie M. Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol 2008; 27: 151-160.
- 4.Ronconi L, Giovagnini L, Marzano C, Betto F, Graziani R, Pilloni G, Fregona D. Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties, and in vitro antitumor activity. Inorg Chem 2005; 44: 1867-1881.
- 5.Lee RX, Li QQ, Reed E. Beta-elemene effectively suppresses the growth and survival of both platinum-sensitive and -resistant ovarian tumor cells. Anticancer Res 2012; 32: 3103-3113.
- 6.Lehnhardt FG, Bock C, Rhn G, Ernestus RI, Hoehn M. Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation. NMR Biomed 2005; 18: 371-382.
- 7.Gottschalk M, Ivanova G, Collins DM, Eustace A, O'Connor R, Brougham DF. Metabolomic studies of human lung carcinoma cell lines using in vitro (1)H NMR of whole cells and cellular extracts. NMR Biomed 2008; 21: 809-819.
- 8.Lodi A, Ronen SM. Magnetic resonance spectroscopy detectable metabolomic fingerprint of response to antineoplastic treatment. PLoS One 2011; 6: e26155.
- 9.Liu G, Hale GE, Hughes CL. Galactose metabolism and ovarian toxicity. Reprod Toxicol 2000; 14: 377-384.
- 10.Xu YK, Ng WG, Kaufman FR, Lobo RA, Donnell GN. Galactose metabolism in human ovarian tissue. Pediatr Res 1989; 25: 151-155.
- 11.Forges T, Monnier-Barbarino P, Leheup B, Jouvet P. Pathophysiology of impaired ovarian function in galactosaemia. Hum Reprod Update 2006; 12: 573-584.
- 12.Ferretti A, D'Ascenzo S, Knijn A, Iorio E, Dolo V, Pavan A, Podo F. Detection of polyol accumulation in a new ovarian carcinoma cell line, CABA I: a1H NMR study. Br J Cancer 2002; 86: 1180-1187.
- 13.Bando T, Fujimura M, Kasahara K, Shibata K, Shirasaki H, Heki U, et al. Exposure to sorbitol induces resistance to cisplatin in human non-small-cell lung cancer cell lines. Anticancer Res 1996; 17: 3345-3348.
- 14.Liu H, Huang D, McArthur DL, Boros LG, Nissen N, Heaney AP. Fructose induces transketolase flux to promote pancreatic cancer growth. Cancer Res 2010; 70: 6368-6376.
- 15.Poliakov E, Managadze D, Rogozin IB. Generalized portrait of cancer metabolic pathways inferred from a list of genes overexpressed in cancer. Genet Res Int 2014; 2014: 646193.
- 16.Zhao Y, Butler EB, Tan M. Targeting cellular metabolism to improve cancer therapeutics. Cell Death Dis 2013; 4: e532.
- 17.Piccart M, Lamb H, Vermorken JB. Current and future potential roles of the platinum drugs in the treatment of ovarian cancer. Annal Oncol 2001; 12: 1195-1203.
- 18.Tatsumura T, Sato H, Mori A, Komori Y, Yamamoto K, Fukatani G, Kuno S. Clinical significance of fucose level in glycoprotein fraction of serum in patients with malignant tumors. Cancer Res 1977; 37: 4101-4103.
- 19.Thompson S, Dargan E, Turner GA. Increased fucosylation and other carbohydrate changes in haptoglobin in ovarian cancer. Cancer Lett 1992; 66: 43-48.
- 20.Kudo T, Nakagawa H, Takahashi M, Hamaguchi J, Kamiyama N, Yokoo H, et al. N-glycan alterations are associated with drug resistance in human hepatocellular carcinoma. Mol Cancer 2007; 6: 32.
- 21.Pochechueva T, Jacob F, Fedier A, Heinzelmann-Schwarz V. Tumor-associated glycans and their role in gynecological cancers: accelerating translational research by novel high-throughput approaches. Metabolites 2012; 2: 913-939.
- 22.Hu Z, Gao J, Zhang D, Liu Q, Yan L, Gao L, et al. High expression of Lewis y antigen and CD44 is correlated with resistance to chemotherapy in epithelial ovarian cancers. PloS One 2013; 8: e57250.
Copyright
© 2016, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Cisplatin Resistant Patterns in Ovarian Cell Line Using FTIR and Principle Component Analysis
Zendehdel R, Masoudi-Nejad A, Mohammadzadeh J, H. Shirazi F. Cisplatin Resistant Patterns in Ovarian Cell Line Using FTIR and Principle Component Analysis. Iran J Pharm Res. 2012;11(1):e125775. doi: https://doi.org/10.22037/ijpr.2012.1079
FTIR Biospectroscopy Investigation on Cisplatin Cytotoxicity in Three Pairs of Sensitive and Resistant Cell Line
Farhadi E, Kobarfard F, H. Shirazi F. FTIR Biospectroscopy Investigation on Cisplatin Cytotoxicity in Three Pairs of Sensitive and Resistant Cell Line. Iran J Pharm Res. 2016;15(1):e125097. doi: https://doi.org/10.22037/ijpr.2016.1775
Patterns Prediction of Chemotherapy Sensitivity in Cancer Cell lines Using FTIR Spectrum, Neural Network and Principal Components Analysis
Zendehdel R, Masoudi-Nejad A, H. Shirazi F. Patterns Prediction of Chemotherapy Sensitivity in Cancer Cell lines Using FTIR Spectrum, Neural Network and Principal Components Analysis. Iran J Pharm Res. 2012;11(2):e125852. doi: https://doi.org/10.22037/ijpr.2012.1141
Intracellular GSH Alterations and Its Relationship to Level of Resistance following Exposure to Cisplatin in Cancer Cells
Jamali B, Nakhjavani M, Hosseinzadeh L, Amidi S, Nikounezhad N, et al. Intracellular GSH Alterations and Its Relationship to Level of Resistance following Exposure to Cisplatin in Cancer Cells. Iran J Pharm Res. 2015;14(2):e125339. doi: https://doi.org/10.22037/ijpr.2015.1661
Interaction of Cisplatin with Cellular Macromolecules: A Fourier Transform Infrared Spectroscopy Study
H.Shirazi F, Wong PT, Goel R. Interaction of Cisplatin with Cellular Macromolecules: A Fourier Transform Infrared Spectroscopy Study. Iran J Pharm Res. 2022;2(1):e127602. doi: https://doi.org/10.22037/ijpr.2010.28
- Scopus by DOI: 0
Last Update: 1 month ago
- Scopus by Title: 0
Last Update: 1 month ago
- Scopus by Title (Ref): 0
Last Update: 1 month ago
- CrossRef: 0
Last Update: 4 days ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Author(s):